Evidence map›Paper›PMID 41975087›Full record

ReviewAnalytical and bioanalytical chemistry2026

Recent advances on nanozyme-driven technology for detecting pharmaceutical and toxic molecules.

Jingshi Lü, Wenjing Wang, Yu Zhang, Xueqian Xia, Yaoxuan Fan, Yuhan Zhou, Ying Tu, Jia-Wei Shen, Wei Duan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingshi Lü *Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Wenjing Wang *Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Yu Zhang *Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Xueqian XiaZhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Yaoxuan FanZhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Yuhan ZhouZhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Ying TuZhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China.
Jia-Wei ShenZhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China. shen.jiawei@hotmail.com.
Wei DuanZhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China. duanweichem@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate analysis of pharmaceutical and toxic molecules is crucial for public health and safety. Nanozymes, nanomaterials with enzyme-like catalytic activities, have emerged as transformative tools to address this need. This review begins by classifying nanozymes and defining their core properties, followed by a systematic summary of how they integrate with major detection technologies, including colorimetry, fluorescence, electrochemistry, immunoassays, surface-enhanced Raman spectroscopy (SERS), and emerging multimodal techniques to enhance analytical performance. It then presents specific applications across diverse pharmaceutical and toxic targets, such as antibiotics, pesticides, traditional Chinese medicine components, toxins, and drug metabolites. The review further addresses critical challenges, including catalytic efficiency, selectivity, and biocompatibility, and outlines future directions for rational design and intelligent diagnostics. By providing a comprehensive overview of recent advances and persistent hurdles, this review aims to pave the way for continued innovation and practical translation in the field of nanozyme-based detection.

Indexed as

NanostructuresBiosensing TechniquesCatalysisColorimetryHumansPharmaceutical PreparationsSpectrum Analysis, RamanPharmaceutical PreparationsColorimetryFluorimetryNanozyme detectionPharmaceutical moleculesToxic molecules

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.